Turn Therapeutics' shares jumped about 15% this week. Investors seemed excited after the company's talk at a big healthcare event.



The CEO boasted about their new drug. It's for a rare genetic thing. Just got approved in the US and Europe. Could be worth over $1.5 billion worldwide. Pretty big deal.

They're feeling good about money. The new drug might help them break even soon. No need to beg for cash, it seems. That's kind of a relief for investors.

The drug's just hitting the market. Early numbers coming soon. Everyone's curious how it's selling. Will patients actually use it? We'll see.

Turn Therapeutics is all about rare diseases. They're doing some cool stuff. Lots of people think they might be the next big thing in biotech. But who knows, right? It's not entirely clear how it'll all play out.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
0/400
No comments
Trade Crypto Anywhere Anytime
qrCode
Scan to download Gate App
Community
English
  • 简体中文
  • English
  • Tiếng Việt
  • 繁體中文
  • Español
  • Русский
  • Français (Afrique)
  • Português (Portugal)
  • Bahasa Indonesia
  • 日本語
  • بالعربية
  • Українська
  • Português (Brasil)